Polymorphism -930A > G of the cytochrome B gene is a novel genetic marker of predisposition to bronchial asthma

Terapevticheskii Arkhiv

Volumn 81, Issue 3, 2009, Pages 31-35

  Polonikov, A V ^a   Ivanov, V P ^a   Solodilova, M A ^a   Kozhukhov, M A ^a   Panfilov, V I ^a   Bulgakova, I V ^a  

^a NONE

Author keywords

Antioxidant enzymes; Association analysis; Bronchial asthma; Cytochrome B; Genetic polymorphism; Interaction genotype envimnment; Linkage equilibrium; Smoking; Vegetable

Indexed keywords

CYBA PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ALLELE; ARTICLE; ASTHMA; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; MALE; SMOKING;

ALLELES; ASTHMA; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; NADPH OXIDASE; POLYMORPHISM, GENETIC; SMOKING;

EID: 67449158716     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fujisawa T. Role of oxygen radicals on bronchial asthma. Curr. Drug Targets Inflamm. Allergy 2005; 4: 505-509.
2. Rahman I., Biswas S. K., Kode A. Oxidant and antioxidant balance in the airways and airway diseases. Eur. J. Pharmacol. 2006; 533: 222-239.
3. Lee Y. L, Lin Y. C, Lee Y. C. et al. Glutathione S-transferase PI gene polymorphism and air pollution as interactive risk factors for childhood asthma. Clin. Exp. Allergy 2004; 34: 1707-1713.
4. Mak J. C, Leung H. C, Ho S. P. et al. Po1ymorphoisms in manganese superoxide dismutase and catalase genes: functional study in Hong Kong Chinese asthma patients. Clin. Exp. Allergy 2006; 36: 440-447.
5. Polonikov A. V., Ivanov V. P., Solodilova M. A. et al. The relationship between Po1ymorphoisms in the glutamate cysteine ligase gene and asthma susceptibility. Respir. Med. 2007; 101: 2422-2424.
6. Diöge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002; 82: 47-95.
7. Stacker R., Keaney J. F. Jr. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004; 84: 1381-1478.
8. Keaney J. F. Jr. Oxidative stress and the vascular wall: NADPH oxidases take center stage. Circulation 2005; 112: 2585-2588.
9. Babior B. M. NADPH oxidase: an update. Blood 1999; 93: 1464-1476.
10. Dinauer M. C, Pierce E. A., Bruns G. A. P. et al. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J. Clin. Invest. 1990; 86: 1729-1737.
11. Moreno M. U., San Jose G., Orbe J. et al. Preliminary characterisation of the promoter of the human p22phox gene: identification of a new Po1ymorphoism associated with hypertension. FEES Utt. 2003; 542: 27-31.
12. San Jose a, Moreno M. U., Olivdn S. et al. Functional effect of the p22phox 930A/G Po1ymorphoism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 2004; 44: 163-169.
13. Peace N. What does the odds ratio estimate in a case-control study? Int. J. Epidemiol. 1993; 22: 1189-1192.
14. Hill W. G. Estimation of linkage disequilibrium in randomly matuig populations. Heredity 1974; 33: 229-239.
15. Liu P Y., Zhang Y. Y., Lu Y. et al. A survey of haplotype variants at several disease candidate genes: the importance of rare vanants for complex diseases. J. Med. Genet. 2005; 42: 221
16. Monteleone C. A., Sherman A. R. Nutrition and asthma. Arch. Intern. Med. 1997; 157: 23-34.
17. Sackesen C, Ercan H, Dizdar E. et al. A comprehensive evaluation of the enzymatic and nonenzymatic antioxidant systems in childhood asthma. J. Allergy Clin. Immunol. 2008; 122(1): 78-85.